Clariant Sells Specialty Silicones Business

GenNx360 Capital Partners, a private equity firm focused on industrial business-to-business companies with $100 million to $1 billion in revenues, announced today that it has acquired Clariant Corporation's Specialty Silicones business, which has been renamed SiVance, LLC. GenNx360 identified the specialty chemicals industry as a key area for investment and this transaction represents its first investment in this sector.

SiVance specializes in the use of silicone-based chemistry to produce high value added, specialty products for use in the personal care, pharmaceutical, electronics and construction markets. The business employs approximately 120 people and operates out of its facility located in Gainesville, Florida.

"We specifically targeted the specialty chemicals industry for investment, and we're excited about this transaction as we believe SiVance represents an excellent platform for growth both organically and through acquisition," said Art Harper, a GenNx360 founding partner. "With Craig Stafford as CEO, the strong management team currently in place, and capital support from GenNx360, SiVance is well positioned to leverage its current position in the marketplace as a leading developer of specialty silicone-based products."

Including SiVance, GenNx360 has completed four industry platform investments in each of the following sectors: specialty chemicals, precision machining, asset light logistics, and business process outsourcing. In addition, SiVance represents the third transaction completed by GenNx360 in 2009.

Financial terms of the transaction were not disclosed.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.